KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC

Otros idiomas Kiniksa Pharmaceuticals International, plc

Acciones

KNSA

GB00BRXB0C07

Farmacéuticos

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 17/01/2025			Varia. Cinco días.	Varia. 1 de enero.
18,54 ^USD	+0,82 %		+2,04 %	-6,27 %

13/01	Kiniksa Pharmaceuticals International, plc ofrece una previsión de ingresos para el año 2025	CI
13/01	Kiniksa Pharmaceuticals International, plc Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 01:30 PM

Otros idiomas

Kiniksa Pharmaceuticals International, plc Provides Revenue Guidance for the Year 2025	13/01
Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance	13/01
Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference	06/01
Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference	26/11
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $357,680, According to a Recent SEC Filing	20/11
Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference	12/11
Kiniksa Pharmaceuticals Partners with GRAMMY Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted Campaign to Drive Awareness of Recurrent Pericarditis	29/10/24
Kiniksa Pharmaceuticals Q3 Loss Narrows, Revenue Rises	29/10/24
Earnings Flash (KNSA) KINIKSA PHARMACEUTICALS Posts Q3 Revenue $112.2M	29/10/24
Kiniksa Pharmaceuticals International : Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution Form 8 K	29/10/24
Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution	29/10/24
Kiniksa Pharmaceuticals International, plc Provides Revenue Guidance for 2024	29/10/24
Kiniksa Pharmaceuticals International, plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	29/10/24
Kiniksa Pharmaceuticals Partners with GRAMMY® Award-Winning Singer-Songwriter, Carly Pearce, in Expansion of Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis	28/10/24
Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024	22/10/24
Kiniksa Pharmaceuticals International, plc Appoints M. Cantey to the Board	07/10/24
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted Campaign to Drive Awareness of Recurrent Pericarditis	02/10/24
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis	01/10/24
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $437,325, According to a Recent SEC Filing	25/09/24
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) dropped from S&P Biotechnology Select Industry Index	23/09/24
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) dropped from S&P TMI Index	23/09/24
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference	28/08/24
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $3,491,947, According to a Recent SEC Filing	26/07/24
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $578,966, According to a Recent SEC Filing	26/07/24
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $601,108, According to a Recent SEC Filing	26/07/24

Conviértase en miembro para acceder a más noticias.

Inscripción 100% Gratuita

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Kiniksa Pharmaceuticals International, plc

Acciones

KNSA

GB00BRXB0C07

Farmacéuticos

Otros idiomas

Filtros